ALPINE IMMUNE SCIENCES, INC. License Agreements
6 Contracts & Agreements
- Letter Agreement, dated December 20, 2023, between Alpine Immune Sciences Inc. and AbbVie Global Enterprises Ltd. amending the Option and License Agreement, dated June 17, 20 (Filed With SEC on March 20, 2024)
- Letter Agreement, dated April 12, 2022, between Alpine Immune Sciences Inc. and AbbVie Global Enterprises Ltd. amending the Option and License Agreement, dated June 17, 2017, by... (Filed With SEC on August 11, 2022)
- Option and License Agreement, dated June 17, 2020, by and between the Company and AbbVie Ireland Unlimited Company (Filed With SEC on August 11, 2020)
- License and Research Agreement Amendment No. 2 by and between AIS Operating Co., Inc. and Kite Pharma, Inc., effective as of October 17, 2018 (Filed With SEC on March 18, 2019)
- License and Research Agreement Amendment No. 1 by and between AIS Operating Co., Inc. and Kite Pharma, Inc., effective as of October 20, 2017 (Filed With SEC on October 24, 2017)
- License and Research Agreement by and between Alpine Immune Sciences, Inc. and Kite Pharma, Inc., effective as of October 26, 2015 (Filed With SEC on October 24, 2017)
